Bridgebio Oncology Therapeutics, Inc. · NASDAQ:BBOT
BridgeBio Pharma LLC reported a 17.50% stake in Bridgebio Oncology Therapeutics, Inc. (Schedule 13D)
Event Aug 11, 2025 · Filed Aug 18, 2025
BridgeBio Pharma LLC reported a 17.50% stake in Bridgebio Oncology Therapeutics, Inc., 13,878,554 shares, with active intent on Aug 11, 2025. Filed Aug 18, 2025 (Schedule 13D).
- Stake
- 17.50%
- Shares
- 13,878,554
- Intent
- Active
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BridgeBio Pharma LLC | 17.50% | 13,878,554 |
| BridgeBio Pharma, Inc. | 17.50% | 13,878,554 |